Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
Being AI (BAI) / HY23

Cash depleted to NZD 0.005m as ACE shell awaits Being AI RTO

With no operating revenue and equity deficit reset from NZD 547.5m to NZD 0.7m, viability now hinges on the pending reverse takeover.

Technology / AI and digital infrastructure

BAI revenue trajectory

Revenue context before the current result.

↗
Loading chart...
HY24 was $0m, versus $0m in HY23.

BAI operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
HY24 was -$0.06m, versus -$0.06m in HY23.

BAI NPAT trajectory

Statutory profit after tax across covered periods.

↗
Loading chart...
HY24 was -$0.1m, versus -$0.1m in HY23.

BAI net debt

Borrowings less cash across covered periods.

↗
Loading chart...
HY23 was $0.46m, versus $0.37m in HY22.
Release date
28 November 2022
Published
23 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

HY23 vs HY22

Revenue

$0m

flat vs $0m

Net profit after tax

−$0.1m

+99.9% ↑ vs −$83.4m

Net cash inflow from operating activities

−$0.06m

+99.9% ↑ vs −$61.1m

Profit before tax

−$0.1m

+99.9% ↑ vs −$83.4m

Cash and cash equivalents

$0.01m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Total assets

—

— vs $42m

What changed

This release reports a shell entity in transition

The company traded as ACE during the period and is now disclosed under the Being AI (BAI) identifier ahead of a reverse-takeover (RTO) transaction proposal flagged for the first half of calendar 2023. Treating the result as a like-for-like operating comparison would be misleading.

Operating revenue was nil in both HY23 and HY22 (0.0%). Reported loss before tax narrowed to NZD 0.1m from NZD 83.4m, and NPAT moved in lockstep, with PBT growth and NPAT growth both at 99.9% and a zero PBT–NPAT gap. The prior-period loss reflected a one-off charge consistent with the carrying-value reset visible on the balance sheet, not an operating cost base.

Cash and equivalents fell to NZD 0.005m from NZD 8.0m. Related-party advances (unsecured) rose to NZD 0.467m from NZD 0.380m, a 22.9% increase. Total equity moved from a NZD 547.5m deficit to a NZD 0.7m deficit, confirming a capital reset rather than operating earnings recovery.

What matters

Liquidity is effectively exhausted

  • Cash of NZD 0.005m against an HY23 operating cash outflow of NZD 0.059m means the entity is being kept alive by related-party funding. The 22.9% increase in unsecured related-party advances is the funding mechanism, and any delay or repricing of that support is an existential risk before the RTO closes.
  • The headline "improvement" is structural, not operational. PBT and NPAT both improved 99.9% because the prior comparable carried a large non-recurring charge that was extinguished alongside the NZD 546.8m reduction in the equity deficit. With no revenue either period, there is no underlying earnings trajectory to read from this result.
  • The result is contingent on a transaction, not a business. Management's stated intent is to deliver an RTO proposal in 1H calendar 2023. Until terms, vendor consideration, and the post-deal capital structure are disclosed, investors are pricing optionality on a transaction rather than cash flows from operations.

Expectations

No revenue, EBITDA, or earnings targets have been supplied, and there is no second-half shape context to anchor against

The only forward statement in the release is the intention to put an RTO transaction proposal to shareholders during the first half of the 2023 calendar year.

What the release supports is that the existing entity has been wound down to a near-shell state with related-party funding bridging it to a transaction. What the release does not support is any view on the target asset's revenue, margins, or capital requirements. The gap matters because the share-price reference value is now entirely a function of the RTO terms, which are not yet on the table.

Quality of result

There is no operating result to assess for durability

With zero revenue in both periods, no segment reporting, and no EBITDA disclosure, conventional measures of earnings quality (cash conversion, gross margin, working-capital intensity) are not applicable. The 99.9% improvement in PBT and NPAT is an artefact of the prior period's non-recurring charge falling out of the comparable, not a recurring earnings trend.

The balance-sheet movements reinforce this read. The reduction of the equity deficit from NZD 547.5m to NZD 0.7m is consistent with a capital reorganisation or write-off rather than retained-earnings generation. The cash burn of NZD 0.059m during the half is small in absolute terms but consumed essentially the entire opening liquidity buffer (HY22 closing cash was NZD 8.0m; HY23 closing cash is NZD 0.005m), with related-party advances filling the gap. This is a financing-supported, not operations-supported, outcome.

Unresolved

Open questions

What are the indicative terms of the RTO transaction, including the target asset, consideration structure, and post-deal share count?
How is the related-party funding line (NZD 0.467m of unsecured advances) priced, dated, and conditioned, and is it committed through to RTO completion?
Why did total equity move from a NZD 547.5m deficit to a NZD 0.7m deficit, and is any portion of that reset reversible if the RTO does not proceed?
What happens to the listing and shareholder register if the 1H 2023 RTO timeline slips?
Are there any contingent liabilities, tax positions, or legacy claims that would survive into the Being AI vehicle post-transaction?

This briefing cannot assess the economics of the prospective RTO target because no information about the incoming business, its revenue, or its capital structure has been disclosed in this release.

Chat

Ask about BAI HY23

Ask follow-up questions about Being AI's HY23 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about BAI HY23

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Being AI's HY23 result.

What are the indicative terms of the RTO transaction, including the target asset, consideration structure, and post-deal share count?Why does "Liquidity is effectively exhausted" matter?How strong was the cash and earnings quality in HY23?What should I watch next for BAI after HY23?

Checking account...

Data appendix

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

ACE Half Year Financial Statements

HY23 / financial report↗

ACE Results for release to the market

HY23 / results announcement↗

ACE Results for release to the market

HY23 / results release↗

Prior comparable period

Half Year financial statements

HY22 / financial report↗

Results for announcement to the market

HY22 / results release↗

Related insights

Cross-company views selected from the metrics in this briefing.

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 0.0pp.

→

Revenue growth context

Revenue growth was 0.0% for this reporting period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when BAI publishes next

Get the next Being AI briefing and related NZX reporting-season updates by email.